Status:
COMPLETED
Evaluation of Clinical Signs and Symptoms of Chronic Heart Failure in Patients Treated With Candesartan Cilexetil in Croatia
Lead Sponsor:
AstraZeneca
Conditions:
Chronic Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine whether treatment with candesartan cilexetil for at least 6 months in patients with chronic heart failure improves clinical signs and symptoms of chronic hear...
Eligibility Criteria
Inclusion
- Patients with diagnosed chronic heart failure
- Patients treated for at least 6 months with candesartan cilexetil
- Signed Informed consent
Exclusion
- Hypersensitivity to candesartan cilexetil
- Pregnancy / lactation
- Severe hepatic impairment
Key Trial Info
Start Date :
September 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2010
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00984529
Start Date
September 1 2009
End Date
February 1 2010
Last Update
January 7 2011
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Biograd na Moru, Croatia
2
Research Site
Bjelovar, Croatia
3
Reserach Site
Čakovec, Croatia
4
Research Site
Karlovac, Croatia